Joined May 2015
- Tweets 337
- Following 110
- Followers 378
- Likes 1,054
40 Photos and videos
Maxwell Meng retweeted
2 Aug 2025
Bladder cancer variants share aggressive features including a CA125 cell state and targetable TM4SF1 expression | Nature Communications nature.com/articles/s41467-0…
1
12
49
4,274
18 Jun 2025
Yesssss! So fortunate to have @KShee11 match here for fellowship in Urologic Oncology @UCSFUrology
2
10
1,404
Maxwell Meng retweeted
5 Nov 2024
Dr. Washington an emerging leader in prostate cancer research has received the 2024 PCF Young Investigator Award! This prestigious recognition highlights his innovative research into the social factors influencing prostate cancer outcomes. @SamWashUro
tiny.ucsf.edu/W8JHqK
5
10
85
5,913
20 Jun 2024
RT @UCSFUrology: Congratulations to Dr. Zachary Kornberg for matching with the UCSF UroOnc fellowship program. @drkornberg
Welcome to the…
9
20 Jun 2024
Excited to welcome @drkornberg back home to UCSF @UCSFUrology for fellowship in urologic oncology @SUO_YUO
1
2
15
1,937
Maxwell Meng retweeted
19 Dec 2023
Congratulations to our 13 new @UrologyCareFdn Research Scholar awardees! The UCF’s Research Scholar Awards support future research leaders and ensure they receive the necessary training and guidance for a successful research career.
Learn more here ➡️ bit.ly/3TxtibH
7
14
66
48,005
Maxwell Meng retweeted
25 May 2023
Meet @jonchou05 of @UCSFMedicine a recipient of a Bladder Cancer Advocacy Network's 2023 #BladderCancer Young Investigator Award. You can also read about the other recipients here: bcan.org/young-investigator-…
2
5
30
7,888
Maxwell Meng retweeted
23 Mar 2023
We are pleased to announce the 2023 cohort of mentees for the #USMART Academy. We can ensure future success for #urology by equipping the next generation to give back to the urological research community. #AUA
Click here ➡️ bit.ly/3TMfGqw
11
12
92
56,032
Maxwell Meng retweeted
10 Mar 2023
Congrats to our team in Milano at #eau23, @RenuEapen presenting #LuTectomy trial data in packed Plenary @PeterMacCC
6
42
3,221
Maxwell Meng retweeted
12 Jan 2023
Save-the-Date!
UroOnc Fellowship Virtual Open House
🗓️Thursday, 1/26/2023
⏰5:00PM-6:00PM PST
✍️Register here: tiny.ucsf.edu/KKKV1S
@Uro_Max @SimaPorten
3
2
1,454
Maxwell Meng retweeted
27 Oct 2022
Very proud of this 💫 of @USANZUrology Congratulations @RenuEapen so very well deserved 🥳@declangmurphy @DrMHofman @OconnellProf @PeterMacCC
15
11
72
Maxwell Meng retweeted
11 Oct 2022
Check out our @NatRevUrol review to learn how prostate cancer cells hijack naturally occurring cell stress coping mechanisms for their own benefit and how this could be targeted for therapy! @KShee11 @HeikoYangMDPhD @PeterLonergan @haognguyen @UCSFUrology
nature.com/articles/s41585-0…
2
10
48
Maxwell Meng retweeted
16 Aug 2022
Join us for the @UCSFUrology Residency Virtual Open House!
🗓️Monday, 8/22/2022
⏰5:30-6:30PST
✍️Register Here: tinyurl.com/ucsf0822
@ben_breyer @lindsayahampson @SamWashUro @AShindelGHI
7
20
4 Aug 2022
2
19
Maxwell Meng retweeted
28 Jul 2022
The UCSF Dept. of Urology is recruiting!
Click the link(s) below to learn more.
tiny.ucsf.edu/CancerBiology
tiny.ucsf.edu/GeneralUrologi…
tiny.ucsf.edu/PediatricUrolo…
tiny.ucsf.edu/UrologicOncolo…
4
13
Maxwell Meng retweeted
22 Jun 2022
Welcome Class of 2028!
James Nie, MD, MBA @jamesnie93
Leah Ibrahim Puri, MD, MA @leahipuri
Grace Lee, MD @grace_syl
Emily Hacker, MD @hacker_emc
1
7
67
Maxwell Meng retweeted
3 Jun 2022
Everolimus did not show a significant DFS or OS advantage in adjuvant RCC. This study probably draws a line under the investigation of mTOR (TORC1/2) in RCC and draws a line under adjuvant targeted therapies in RCC. Everolimus role is relatively limited. #ASCO22
3
28
106